From Name:
From Email:
To Name:
To Email:

Optional Message:

Cardinal Health Announces FDA Approval of the INCRAFT AAA Stent Graft System

from Cath Lab Digest

Cordis, a Cardinal Health company, announced that the U.S. Food and Drug Administration has approved its INCRAFT® AAA Stent Graft System for use in complex access anatomies. The INCRAFT system is an ultra-low profile and flexible endovascular aneurysm repair system designed to treat infrarenal abdominal aortic aneurysms. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063